| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.5 |